logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • Press releases
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Analyst notes
    • Constitutional documents
    • Investor news
    • Corporate governance
    • Investor contacts
    • Company information

AIM Rule 26

Home > Investor relations > AIM Rule 26

The information below is disclosed in accordance with AIM Rule 26 and details are updated on a regular basis:

Business Description – Click here 

Directors Names & Biographies - Click here

Corporate Governance – Click here

UK Takeover Code - The Company is subject to the UK City Code on Takeovers and Mergers.

Current constitutional documents such as articles of association and memorandum of association - Click here

Details of any other exchanges or trading platforms - The company’s shares are not traded on any other stock exchange.

The number of aim securities in issue (noting any held as treasury shares) – Click here 

The identity and percentage holdings of significant shareholders – Click here 

Details of any restrictions on the transfer of aim securities– Click here 

Annual and interim financial reports - – Click here 

Regulatory news – Click here 

Aim admission document and circulars - Click here 

Advisors – Click here

Country of incorporation: England and Wales
Company registration number: 09761507
Main country of operation: United Kingdom 

Latest reports

share price graph

05 December 2022

Annual Report and Accounts 2022

View all reports >

Investor News

Wednesday February 03, 2021

Genedrive close to hitting the market with coronavirus tests

Monday March 20, 2023

Genedrive up 10% on Greater Manchester green light

Thursday February 09, 2023

Genedrive gets a NICE boost to help shares move higher

View all news >

  • Privacy
  • Terms of use
  • Site map

© 2017-23 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose